1. Home
  2. KTF vs IDYA Comparison

KTF vs IDYA Comparison

Compare KTF & IDYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo DWS Municipal Income Trust

KTF

DWS Municipal Income Trust

HOLD

Current Price

$9.11

Market Cap

365.1M

Sector

Finance

ML Signal

HOLD

Logo IDEAYA Biosciences Inc.

IDYA

IDEAYA Biosciences Inc.

HOLD

Current Price

$33.97

Market Cap

2.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KTF
IDYA
Founded
1988
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Finance Companies
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
365.1M
2.9B
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
KTF
IDYA
Price
$9.11
$33.97
Analyst Decision
Strong Buy
Analyst Count
0
14
Target Price
N/A
$49.42
AVG Volume (30 Days)
103.3K
926.1K
Earning Date
01-01-0001
11-04-2025
Dividend Yield
3.54%
N/A
EPS Growth
N/A
N/A
EPS
0.39
N/A
Revenue
N/A
$214,834,000.00
Revenue This Year
N/A
$2,434.86
Revenue Next Year
N/A
N/A
P/E Ratio
$23.10
N/A
Revenue Growth
N/A
5377.66
52 Week Low
$7.40
$13.45
52 Week High
$9.12
$37.08

Technical Indicators

Market Signals
Indicator
KTF
IDYA
Relative Strength Index (RSI) 42.49 53.65
Support Level $9.09 $33.12
Resistance Level $9.21 $37.08
Average True Range (ATR) 0.05 1.45
MACD -0.00 -0.32
Stochastic Oscillator 20.00 21.97

Price Performance

Historical Comparison
KTF
IDYA

About KTF DWS Municipal Income Trust

DWS Municipal Income Trust is a closed-ended fixed income mutual fund launched and managed by Deutsche Investment Management Americas, Inc. The company invests in the fixed income markets of the United States. The fund invests in investment-grade tax-exempt municipal securities which are exempt from federal income tax. The fund benchmarks the performance of its portfolio against the Barclays Municipal Bond Index. The Fund invests in various states, such as Texas, Florida, Pennsylvania, Illinois, and California.

About IDYA IDEAYA Biosciences Inc.

IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug discovery with extensive capabilities in identifying and validating translational biomarkers to develop targeted therapies for select patient populations that are likely to benefit from these targeted therapies. The company's clinical-stage product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275/GSK959 (Werner Helicase), IDE161 (PARG), and IDE705/GSK101 (Pol Theta Helicase). In addition, it also working on other development candidates and has multiple earlier-stage preclinical programs.

Share on Social Networks: